• 1
    Moir RD, Spann TP. The structure and function of nuclear lamins: implications for disease. Cell Mol Life Sci 2001; 58: 17481757.
  • 2
    Hutchison CJ, Worman HJ. A-type lamins: guardians of the soma? Nat Cell Biol 2004; 6: 10621067.
  • 3
    Lin F, Worman HJ. Structural organization of the human gene encoding nuclear lamin A and nuclear lamin C. J Biol Chem 1993; 268: 1632116326.
  • 4
    Jacob KN, Garg A. Laminopathies: multisystem dystrophy syndromes. Mol Genet Metab 2006; 87: 289302.
  • 5
    Wydner KL, McNeil JA, Lin F, Worman HJ, Lawrence JB. Chromosomal assignment of human nuclear envelope protein genes LMNA, LMNB1, and LBR by fluorescence in situ hybridization. Genomics 1996; 32: 474478.
  • 6
    Hegele RA, Cao H, Harris SB et al. Genetic variation in LMNA modulates plasma leptin and indices of obesity in aboriginal Canadians. Physiol Genomics 2000; 3: 3944.
  • 7
    Hegele RA, Huff MW, Young TK. Common genomic variation in LMNA modulates indexes of obesity in Inuit. J Clin Endocrinol Metab 2001; 86: 27472751.
  • 8
    Wolford JK, Hanson RL, Bogardus C, Prochazka M. Analysis of the lamin A/C gene as a candidate for type II diabetes susceptibility in Pima Indians. Diabetologia 2001; 44: 779782.
  • 9
    Weyer C, Wolford JK, Hanson RL et al. Subcutaneous abdominal adipocyte size, a predictor of type 2 diabetes, is linked to chromosome 1q21-q23 and is associated with a common polymorphism in LMNA in Pima Indians. Mol Genet Metab 2001; 72: 231238.
  • 10
    Murase Y, Yagi K, Katsuda Y et al. An LMNA variant is associated with dyslipidemia and insulin resistance in the Japanese. Metabolism 2002; 51: 10171021.
  • 11
    Steinle NI, Kazlauskaite R, Imumorin IG et al. Variation in the lamin A/C gene: associations with metabolic syndrome. Arterioscler Thromb Vasc Biol 2004; 24: 17081713.
  • 12
    Mesa JL, Loos RJ, Franks PW et al. Lamin A/C polymorphisms, type 2 diabetes, and the metabolic syndrome: case-control and quantitative trait studies. Diabetes 2007; 56: 884889.
  • 13
    Wegner L, Andersen G, Sparsø T et al. Common variation in LMNA increases susceptibility to type 2 diabetes and associates with elevated fasting glycemia and estimates of body fat and height in the general population: studies of 7,495 Danish whites. Diabetes 2007; 56: 694698.
  • 14
    Owen KR, Groves CJ, Hanson RL et al. Common variation in the LMNA gene (encoding lamin A/C) and type 2 diabetes: association analyses in 9,518 subjects. Diabetes 2007; 56: 879883.
  • 15
    Mancini MA, Shan B, Nickerson JA, Penman S, Lee WH. The retinoblastoma gene product is a cell cycledependent, nuclear matrix-associated protein. Proc Natl Acad Sci USA 1994; 91: 418422.
  • 16
    Ozaki T, Saijo M, Murakami K et al. Complex formation between lamin A and the retinoblastoma gene product: Identification of the domain on lamin A required for its interaction. Oncogene 1994; 9: 26492653.
  • 17
    Kennedy BK, Barbie DA, Classon M, Dyson N, Harlow E. Nuclear organization of DNA replication in primary mammalian cells. Genes Dev 2000; 14: 28552868.
  • 18
    Markiewicz E, Dechat T, Foisner R, Quinlan RA, Hutchison CJ. Lamin A/C binding protein LAP2alpha is required for nuclear anchorage of retinoblastoma protein. Mol Biol Cell 2002; 13: 44014413.
  • 19
    Johnson BR, Nitta RT, Frock RL et al. A-type lamins regulate retinoblastoma protein function by promoting subnuclear localization and preventing proteasomal degradation. Proc Natl Acad Sci USA 2004; 101: 96779682.
  • 20
    Zastrow MS, Vlcek S, Wilson KL. Proteins that bind A-type lamins: integrating isolated clues. J Cell Sci 2004; 117: 979987.
  • 21
    Gruenbaum Y, Margalit A, Goldman RD, Shumaker DK, Wilson KL. The nuclear lamina comes of age. Nat Rev Mol Cell Biol 2005; 6: 2131.
  • 22
    Mariappan I, Parnaik VK. Sequestration of pRb by cyclin D3 causes intranuclear reorganization of lamin A/C during muscle cell differentiation. Mol Biol Cell 2005; 16: 19481960.
  • 23
    Ivorra C, Kubicek M, González JM et al. A mechanism of AP-1 suppression through interaction of c-Fos with lamin A/C. Genes Dev 2006; 20: 307320.
  • 24
    Dreuillet C, Tillit J, Kress M, Ernoult-Lange M. In vivo and in vitro interaction between human transcription factor MOK2 and nuclear lamin A/C. Nucleic Acids Res 2002; 30: 46344642.
  • 25
    Holaska JM, Lee KK, Kowalski AK, Wilson KL. Transcriptional repressor germ cell-less (GCL) and barrier to autointegration factor (BAF) compete for binding to emerin in vitro. J Biol Chem 2003; 278: 69696975.
  • 26
    Hubner S, Eam JE, Hubner A, Jans DA. Laminopathy-inducing lamin A mutants can induce redistribution of lamin binding proteins into nuclear aggregates. Exp Cell Res 2006; 312: 171183.
  • 27
    Lelliot CJ, Logie L, Sewter CP et al. Lamin expression in human adipose cells in relation to anatomical site and differentiation state. J Clin Endocrinol Metab 2002; 87: 728734.
  • 28
    Machiels BM, Broers JLV, Raymond Y et al. Abnormal A-type lamin organisation in a human lung carcinoma cell line. Eur J Cell Biol 1995; 67: 328335.
  • 29
    World Health Organization. Obesity: Preventing and Managing the Global Epidemic. In WHO, WHO Technical Report Series 894, Geneva, Switzerland, 2000.
  • 30
    The expert Committee on the Diagnosis and Classification of the DiabetesMellitus. Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Diabetes Care 1997; 20: 11831197.
  • 31
    Rober RA, Weber K, Osborn M. Differential timing of nuclear lamin A/C expression in the various organs of the mouse embryo and the young animal: a developmental study. Development 1989; 105: 365378.
  • 32
    Röber RA, Gieseler RKH, Peters JH, Weber K, Osborn M. Induction of nuclear Lamins A/C in macrophages in in vitro cultures of rat bone marrow precursor cells and human blood monocytes, and in macrophages elicited in vivo by thioglycollate stimulation. Exp Cell Res 1990; 190: 185194.
  • 33
    Broers JL, Machiels BM, Kuijpers HJ et al. A- and B-type lamins are differentially expressed in normal human tissues. Histochem Cell Biol 1997; 107: 505517.
  • 34
    Goldman RD, Gruenbaum Y, Moir RD, Shumaker DK, Spann TP. Nuclear lamins: building blocks of nuclear architecture. Genes Dev 2002; 16: 533547.
  • 35
    Smith J, Al-Amri M, Dorairaj P, Sniderman A. The adipocyte life cycle hypothesis. Clin Sci 2006; 110: 19.
  • 36
    Peter M, Nigg EA. Ectopic expression of an A-type lamin does interfere with differentiation of lamin A-negative embryonal carcinoma cells. J Cell Sci 1991; 100: 589598.
  • 37
    Lloyd DJ, Trembath RC, Shackleton S. A novel interaction between lamin A and SREBP1: implications for partial lipodystrophy and other laminopathies. Hum Mol Genet 2002; 11: 769777.
  • 38
    Kolehmainen M, Vidal H, Alhava E, Uusitupa MIJ. Sterol regulatory element binding protein 1c (SREBP-1c) expression in human obesity. Obes Res 2001; 9: 706712.
  • 39
    Oberkofler H, Fukushima N, Esterbauer H, Krempler F, Patsch W. Sterol regulatory element binding proteins: relationship of adipose tissue gene expression with obesity in humans. Biochim Biophys Acta 2002; 1575: 7581.
  • 40
    Sewter C, Berger D, Considine RV et al. Human obesity and type 2 diabetes mellitus are associated with alterations in SREBP1 isoform expression that are reproduced ex vivo by tumor necrosis factor-alpha. Diabetes 2002; 51: 10351041.
  • 41
    Auboeuf D, Rieusset J, Fajas L et al. Tissue distribution and quantification of the expression of mRNA of peroxisome proliferator-activated receptors and liver X receptor-alpha in humans. No alteration in adipose tissue of obese and NIDDM patients. Diabetes 1997; 46: 13191327.
  • 42
    Rieusset J, Andreelli F, Auboeuf D et al. Insulin acutely regulates the expression of the peroxisome proliferator-activated receptor-gamma in human adipocytes. Diabetes 1999; 48: 699705.
  • 43
    Montague CT, Prins JB, Sanders L et al. Depot-related gene expression in human subcutaneous and omental adipocytes. Diabetes 1998; 47: 13841391.
  • 44
    Sewter C, Blows F, Considine A, Vidal-Puig A, O'Rahilly S. Differential effects of adiposity on peroxisomal proliferator-activated receptor gamma1 and gamma2 messenger ribonucleic acid expression in human adipocytes. J Clin Endocrinol Metab 2002; 87: 42034207.
  • 45
    Hegele RA, Kraw ME, Ban MR et al. Elevated serum C-reactive protein and free fatty acids among nondiabetic carriers of missense mutations in the gene encoding lamin A/C (LMNA) with partial lipodystrophy. Arterioscler Thromb Vasc Biol 2003; 23: 111116.
  • 46
    Broers JLV, Kuijpers HJH, Östlund C et al. Both lamin A and lamin C mutations cause lamina instability as well as loss of internal nuclear lamin organization. Exp Cell Res 2005; 304: 582592.